The DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Animal models of neurodegenerative diseases
Open accessAbstract
Animal models of adult-onset neurodegenerative diseases have enhanced the understanding of the molecular pathogenesis of Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. Nevertheless, our understanding of these disorders and the development of mechanistically designed therapeutics can still benefit from more rigorous use of the models and from generation of animals that more faithfully recapitulate human disease. Here we review the current state of rodent models for Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. We discuss the limitations and utility of current models, issues regarding translatability, and future directions for developing animal models of these human disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It typically requires additional expression of human tau harboring mutations associated with primary tauopathy (94–96) or seeding mutant human APP knock-in mouse brain with human AD brain-derived tau (97) to develop the tau pathology.”
From Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming (2024) · cites this paper as [94]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Winton, M. J., Lee, E. B., Sun, E., Wong, M. M., Leight, S., Zhang, B., Trojanowski, J., & Lee, V. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6637-10.2011 · Cited by 110
RetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 1×
“Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.”
A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD
Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.010 · Cited by 4,409
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Self-citation
Cited by
Sorted by citations
Items 301–400 of 583
Focusing on oligomeric tau as a therapeutic target in Alzheimer’s disease and other tauopathies
Rayman, J. B. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2206561 · Cited by 11
Inhibition of Oxidative Stress and Related Signaling Pathways in Neuroprotection
Jembrek, M. J. (2024) · Antioxidants · doi:10.3390/antiox13091033 · Cited by 9
Advances in iPSC Technology in Neural Disease Modeling, Drug Screening, and Therapy
Dai, S., Qiu, L., Veeraraghavan, V. P., Sheu, C., & Mony, U. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x18666230608105703 · Cited by 8
Chen, X., 暨南大学广东省非人灵长类动物模型研究重点实验室, 中., Han, R., Liu, Y., Huang, W., Wang, Q., Xiong, X., Zhang, Y., Zhao, J., Li, S.-H., et al. (2023) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2023.241 · Cited by 8
Lü, W., Shue, F., Kurti, A., Jeevaratnam, S., Macyczko, J. R., Roy, B., Izhar, T., Wang, N., Bu, G., Kanekiyo, T., et al. (2024) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2024.10.005 · Cited by 9
Harris, A. R., McGivern, P., & Ooi, L. (2019) · The Neuroscientist · doi:10.1177/1073858419870446 · Cited by 8
Liang, K. X., Kristiansen, C. K., Vatne, G. H., Hong, Y., & Bindoff, L. A. (2020) · Cell and Tissue Research · doi:10.1007/s00441-019-03164-x · Cited by 8
Subject of study—the aging brain
Ivanitskii, G. R., & Morozov, A. A. (2020) · Physics-Uspekhi · doi:10.3367/ufne.2020.06.038791 · Cited by 8
Loss of GDE2 leads to complex behavioral changes including memory impairment
Daudelin, D., Westerhaus, A., Zhang, N., Leyder, E. C., Savonenko, A. V., & Sockanathan, S. (2024) · Behavioral and Brain Functions · doi:10.1186/s12993-024-00234-1 · Cited by 8
Pobran, T. D., Forgrave, L. M., Zheng, Y. Z., Lim, J. G. K., Mackenzie, I. R., & DeMarco, M. L. (2019) · Clinical mass spectrometry · doi:10.1016/j.clinms.2019.07.003 · Cited by 8
Viruega, H., & Gaviria, M. (2021) · Life · doi:10.3390/life11060495 · Cited by 8
Animal Models of Human Disease
(2011) · Progress in molecular biology and translational science · doi:10.1016/c2010-0-65612-4 · Cited by 8
Mouse brain organoids model in vivo neurodevelopment and function and capture differences to humanPreprint
Sanchez, D. J. L.-D., Lindhout, F. W., Anderson, A. J., Pellegrini, L., & Lancaster, M. A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.21.629881 · Cited by 8
Organoids Modeling Stroke in a Petri Dish
Giorgi, C., Castelli, V., d’Angelo, M., & Cimini, A. (2024) · Biomedicines · doi:10.3390/biomedicines12040877 · Cited by 7
Gonul, C. P., Kiser, C., Yaka, E. C., Öz, D., Hunerli, D., Yerlikaya, D., Olcum, M., Keskinoğlu, P., Yener, G., & Genç, Ş. (2024) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2024.103990 · Cited by 8
Palomares, D., Vanparys, A., Jorgji, J., Paître, E., Kienlen‐Campard, P., & Suelves, N. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02118-5 · Cited by 7
Wang, W., Tan, S., Zuo, X., Gao, X., Ma, L., Sun, R., Liang, G., Yin, L., Pu, Y., & Zhang, J. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05293-7 · Cited by 7
LRRK2 decreases microglial actin dynamics by filamentous actin depolymerization and Rac1 inhibition
Kim, B., Suh, Y. H., & Joe, E.-H. (2022) · Animal Cells and Systems · doi:10.1080/19768354.2022.2158219 · Cited by 7
The Difficult Path to the Discovery of Novel Treatments in Psychiatric Disorders
Gribkoff, V. K., & Kaczmarek, L. K. (2023) · Advances in neurobiology · doi:10.1007/978-3-031-21054-9_11 · Cited by 7
Experimental procedures for flow cytometry of wild-type mouse brain: a systematic review
Sharp, R. C., Guenther, D. T., & Farrer, M. J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1281705 · Cited by 7
Urine-derived stem cells in neurological diseases: current state-of-the-art and future directions
Cavaleiro, C., Afonso, G. J. M., Oliveira, P. J., Valero, J., Mota, S. I., & Ferreiro, E. B. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1229728 · Cited by 7
Differential distribution of PINK1 and Parkin in the primate brain implies distinct roles
Liu, Y., Huang, W., Wen, J., Xiong, X., Xu, T., Wang, Q., Chen, X., Zhao, X., Li, S., Li, X., et al. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01140 · Cited by 7
Experimental Parkinson models and green chemistry approach
AKYAZI, Ö., Korkmaz, D., & Cevher, Ş. C. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115092 · Cited by 7
Hurler, C.-A., Liebscher, S., Arzberger, T., & Jäkel, S. (2024) · Brain Communications · doi:10.1093/braincomms/fcae430 · Cited by 7
Lamichhane, S., Seo, J., Jeong, J. H., Lee, S., & Lee, S. (2024) · Archives of Pharmacal Research · doi:10.1007/s12272-024-01527-9 · Cited by 8
Multi-coil TMS for preclinical applications in ultra-high-field MRI
Souza, V. H., Sinisalo, H., Korhonen, J. T., Paasonen, J., Nyrhinen, M., Nieminen, J. O., Koponen, M. A., Kettunen, M. I., Gröhn, O. H. J., & Ilmoniemi, R. J. (2025) · Imaging Neuroscience · doi:10.1162/imag_a_00558 · Cited by 7
Deep brain electrophysiology in freely moving sheep
Perentos, N., Krstulović, M., & Morton, A. J. (2022) · Current Biology · doi:10.1016/j.cub.2021.12.035 · Cited by 8
Disease Modeling of Neurodegenerative Disorders Using Direct Neural Reprogramming
Legault, E. M., Bouquety, J., & Drouin‐Ouellet, J. (2022) · Cellular Reprogramming · doi:10.1089/cell.2021.0172 · Cited by 7
Comparing HD knockin pigs and mice reveals the pathological role of IL-17
Jia, Q., Bai, D., Zheng, X., Zhu, L., Ou, K., Wang, X., Tong, H., Zhang, Y., Wang, J., Zeng, J., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113443 · Cited by 7
Deception and the ethics of placebo
Stoessl, A. J. (2020) · International review of neurobiology · doi:10.1016/bs.irn.2020.03.030 · Cited by 7
Divergent FUS phosphorylation in primate and mouse cells following double-strand DNA damage
Johnson, M. A., Deng, Q., Taylor, G., McEachin, Z. T., Chan, A. W. S., Root, J. T., Bassell, G. J., & Kukar, T. L. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105085 · Cited by 7
Cappella, M., Elouej, S., & Biferi, M. G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.662837 · Cited by 7
Niikura, R., Miyazaki, T., Takase, K., Sasaguri, H., Saito, T., Saido, T. C., & Goto, T. (2022) · Molecular Brain · doi:10.1186/s13041-022-00910-1 · Cited by 7
Engineered microtissue as an anatomically inspired model of Parkinson's disease
Clark, E. M., O’Donnell, J. C., Struzyna, L. A., Chen, H.-C. I., Duda, J. E., & Cullen, D. K. (2020) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2020.07.004 · Cited by 7
Quarta, E., Cohen, E. J., Bravi, R., & Minciacchi, D. (2020) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2020.596200 · Cited by 7
Neurodegeneration emerges at a cellular tipping point between aggregate accumulation and removalPreprint
Cotton, M. W., Venkatesan, S., Beckwith, J. S., Böken, D., Xu, C. K., Fertan, E., Breiter, J. C., Berkowicz, L. E., Salazar, L. S., Schulze, A. T. V., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.08.674880 · Cited by 7
Shida, Y., Endo, H., Owada, S., Inagaki, Y., Sumiyoshi, H., Kamiya, A., Eto, T., & Tatemichi, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-02591-7 · Cited by 6
Otsuka, T., & Matsui, H. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112087 · Cited by 6
Investigational Gene Therapies for Parkinson's Disease
Phielipp, N. M., & Henchcliffe, C. (2025) · CNS Drugs · doi:10.1007/s40263-025-01203-6 · Cited by 6
Neha, N., Mazahir, I., Khan, S. A., Kaushik, P., & Parvez, S. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04078-8 · Cited by 6
Li, J., Ng, K. W., Sung, C. C., & Chung, K. K. K. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16122 · Cited by 6
AI-Based Electroencephalogram Analysis in Rodent Models of Epilepsy: A Systematic Review
Edoho, M. E., Mooney, C., & Wei, L. (2024) · Applied Sciences · doi:10.3390/app14167398 · Cited by 6
Lau, F., Binacchi, R., Brugnara, S., Cumplido-Mayoral, A., Savino, S. D., Khan, I., Orso, A., Sartori, S., Bellosta, P., Carl, M., et al. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.042 · Cited by 6
Song, S., Xie, H., Wang, Q., Sun, X., Xu, J., Chen, R., Zhu, Y., Jiang, L., & Ding, X. (2025) · Nature Communications · doi:10.1038/s41467-025-59457-z · Cited by 6
Inflammation-Mediated Responses in the Development of Neurodegenerative Diseases
Nainu, F., Mamada, S. S., Harapan, H., & Emran, T. B. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_3 · Cited by 6
Labunets, І. F., Panteleymonova, T., Utko, N., Kyryk, V. M., Savosko, S. I., & Litochenko, Z. L. (2023) · INTERNATIONAL NEUROLOGICAL JOURNAL · doi:10.22141/2224-0713.19.4.2023.1010 · Cited by 6
de Mena, L., Smith, M. A., Martin, J., Dunton, K. L., Ceballos‐Diaz, C., Jansen‐West, K. R., Cruz, P. E., Dillon, K. D., Rincón-Limas, D. E., Golde, T. E., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00698-z · Cited by 6
Self-citationThe Neuroepigenetic Landscape of Vertebrate and Invertebrate Models of Neurodegenerative Diseases
Sundaramoorthy, T. H., & Castanho, I. (2022) · Epigenetics Insights · doi:10.1177/25168657221135848 · Cited by 6
Modeling Psychiatric Diseases with Induced Pluripotent Stem Cells
van Hugte, E., & Kasri, N. N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9721-0_15 · Cited by 6
The Potential of Induced Pluripotent Stem Cells to Treat and Model Alzheimer’s Disease
Schulz, J. M. (2021) · Stem Cells International · doi:10.1155/2021/5511630 · Cited by 6
D'adamio, L. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202318479 · Cited by 6
Defective autophagy in a fibroin secretion-deficient silkworm mutant
Xia, J., Chen, H., Wang, Y., Hu, W., Guo, K., Linghu, Q., Guo, P., Wang, X., Xia, Q., Nezis, I. P., et al. (2025) · Autophagy · doi:10.1080/15548627.2025.2510843 · Cited by 5
Dienemann, S., Wohlenberg, O. J., Gerstenberger, J. G., Lavrentieva, A. V., & Pepelanova, I. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1579580 · Cited by 5
Advances in non-human primate models for Alzheimer's disease research
Joho, D., Sato, K., Kumita, W., Saido, T. C., Sasaki, E., & Sasaguri, H. (2025) · Neuroscience Research · doi:10.1016/j.neures.2025.104984 · Cited by 6
Chéron, J., Ranga, A., & Bonnefont, J. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1729102 · Cited by 5
Brown, R. E. (2022) · The EuroBiotech Journal · doi:10.2478/ebtj-2022-0008 · Cited by 5
CRISPR/Cas9 gene editing: A new hope for Alzheimer's disease
Shareena, G., Viswalingam, V., Rajput, M. S., & Kumar, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23841-3.00014-5 · Cited by 4
Non-invasive real-time pulsed Doppler assessment of blood flow in mouse ophthalmic artery
Sharina, I. G., Awad, R., Cobb, S., Martin, E., Marrelli, S. P., & Reddy, A. K. (2025) · Cell Reports Methods · doi:10.1016/j.crmeth.2025.100983 · Cited by 5
Hogan, A. L., Kane, M. A., Chiu, P., Richter, G., Maurel, C., Wu, S., Scherer, N. M., Don, E. K., Lee, A., Blair, I. P., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02159-w · Cited by 5
Bertolli, A. X., Halhouli, O., Weber, M. A., Liu-Martínez, Y., Wendt, L. H., Blaine, B., Thangavel, R., Smadi, S., Pellatz, P. J., Liu, D., et al. (2026) · Methods · doi:10.1016/j.ymeth.2026.04.004 · Cited by 5
da Silva, M. P., Ramalho, D. L., Santos, S. F., Andrade, C. M. B., Yamaguchi, K. K. D. L., Carvalho, R. P., & Souza, A. D. O. (2022) · Research Society and Development · doi:10.33448/rsd-v11i17.38931 · Cited by 5
Functionalized carbon nanotubes—A boon in treating brain diseases
Ghosh, R., Bag, J., Datta, A., Pramanick, A., & Abubakar, I. H. (2023) · Journal of Applied Pharmaceutical Science · doi:10.7324/japs.2023.107158 · Cited by 5
eLemur: A cellular-resolution 3D atlas of the mouse lemur brain
Jeon, H., Kim, J., Kim, J., Choi, Y. K., Ho, C. L. A., Pifferi, F., Huber, D., Feng, L., & Kim, J. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2413687121 · Cited by 5
Advances in human brain proteomics analysis of neurodegenerative diseases
Chen, Y., Wang, X., & Xu, B. (2022) · Human Brain · doi:10.37819/hb.001.001.0197 · Cited by 5
Detection of Soluble and Insoluble Protein Species in Patient-Derived iPSCs
Santarriaga, S., Luecke, I. W., & Ebert, A. D. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1979-7_6 · Cited by 5
Perspectives on current models of Friedreich’s ataxia
Kelekçi, S., Yıldız, A. B., Sevinç, K., Uğurlu-Çimen, D., & Önder, T. T. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.958398 · Cited by 5
Neurodegeneration in a regulatory context: The need for speed
Meerman, J. J., Wolterink, G., Hessel, E. V. S., de Jong, E., & Heusinkveld, H. J. (2022) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2022.100383 · Cited by 5
Direct conversion of fibroblast into neurons for Alzheimer's disease research: a systematic review
Sattarov, R., Toresson, H., Orbjörn, C., & Mattsson-Carlgren, N. (2023) · Journal of Alzheimer’s Disease · doi:10.3233/jad-230119 · Cited by 4
Measuring the replicability of our own research
Brown, R. E. (2024) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2024.110111 · Cited by 5
Insights on pathophysiology of hydrocephalus rats induced by kaolin injection
Zhang, K., Zhou, W., Yu, H., Pang, M., Gao, H., Anwar, F., Yu, K., Zhou, Z., Guo, F., Liu, X., et al. (2024) · FASEB BioAdvances · doi:10.1096/fba.2024-00070 · Cited by 4
Impact of perfusion on neuronal development in human derived neuronal networks
Lisa, D. D., Andolfi, A., Masi, G., Uras, G., Ferrari, P. F., Martinoia, S., & Pastorino, L. (2024) · APL Bioengineering · doi:10.1063/5.0221911 · Cited by 4
Wu, Y., Wang, J., & Zhao, Q. (2024) · Aging and Health Research · doi:10.1016/j.ahr.2024.100215 · Cited by 4
In Vivo Seeding of Amyloid-β Protein and Implications in Modeling Alzheimer’s Disease Pathology
Liu, Q., Song, S., Liu, L., & Hong, W. (2025) · Biomolecules · doi:10.3390/biom15040571 · Cited by 5
Vidal, R., Lopez, I., Ugarte, G., Contreras, D., Piña, R., Godoy, F., Rozas, C., Rubio, D., Mantellero, C. A., Constandil, L., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0323756 · Cited by 4
Pyruvate kinase deficiency links metabolic perturbations to neurodegeneration and axonal protection
Waller, T. J., Collins, C. A., & Dus, M. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102187 · Cited by 4
Panda, M., Fakitsa, M., Markaki, M., & Tavernarakis, N. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115655 · Cited by 4
Wang, X., Hou, R., Chen, Z., Wang, X., Malek, M., & Wang, H. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70563 · Cited by 5
Divergent and convergent TMEM106B pathology in murine models of neurodegeneration and human disease
Du, M., Akerman, S. C., Fare, C. M., Ruan, L., Vidensky, S., Mamedova, L., Koo, K., Lee, J. Y., & Rothstein, J. D. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02087-9 · Cited by 4
Banerjee, S., Chandu, P. M., Sarkar, M., Soni, T. K., Saha, M., Fathah Muhammad, L., Chatterjee, B., & Das, U. (2025) · Neurological Research · doi:10.1080/01616412.2025.2600434 · Cited by 5
García-Martínez, M., Cortez, L. M., Otero, A., Betancor, M., Serrano, B., Bolea, R., Badiola, J. J., & Garza, M. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073579 · Cited by 5
Development and Optimization of a Multilayer Rat Purkinje Neuron Culture
Uggerud, I. M., Kråkenes, T., Hirai, H., Vedeler, C. A., & Schubert, M. (2023) · The Cerebellum · doi:10.1007/s12311-022-01510-4 · Cited by 4
Genetic modifiers of synucleinopathies—lessons from experimental models
Lee, R. M. Q., & Koh, T. (2023) · Oxford Open Neuroscience · doi:10.1093/oons/kvad001 · Cited by 4
Fountain of youth—Targeting autophagy in aging
Danics, L., Abbas, A. A., Kis, B., & Pircs, K. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1125739 · Cited by 4
Omics profile of iPSC-derived astrocytes from Progressive Supranuclear Palsy (PSP) patients
Ravagnani, F. G., Valerio, H. P., Maués, J. H. D. S., de Oliveira, A. N., Puga, R., Griesi‐Oliveira, K., Picosse, F. R., Ferraz, H. B., Catharino, R. R., Ronsein, G. E., et al. (2023) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2023.105847 · Cited by 4
Labunets, І. F., Panteleymonova, T., Kyryk, V. M., Toporova, O. K., & Litoshenko, Z. (2023) · Cell and Organ Transplantology · doi:10.22494/cot.v11i2.155 · Cited by 4
Cell-Engineered Recombinant α-Synuclein: A Gage R&R Validated Protocol
Thakkar, H., Chatterjee, S., Saxena, P., Eerla, R., Wagh, S., Khairnar, A., & Shah, R. P. (2023) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00190 · Cited by 4
Activation of the heat shock response as a therapeutic strategy for tau toxicity
Stanley, T. R., Otero, E. M., Knight, A. L., Saxton, A. D., Ding, X., Borgen, M. A., Kraemer, B. C., Guisbert, K. S. K., & Guisbert, E. (2024) · Disease Models & Mechanisms · doi:10.1242/dmm.050635 · Cited by 4
Nguyen, D. L., Le, M. P. T., Lee, K., Kim, J., Yoon, H. C., & Pham, H. T. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-80369-3 · Cited by 4
Villa, C. D. A., Atudorei, M., Siebner, H. R., & Rickhag, M. (2024) · European Journal of Neuroscience · doi:10.1111/ejn.16622 · Cited by 4
In Vivo Models for Evaluation of Drug Efficacy: Demand and Challenges
Asthana, S., Shukla, V., & Tripathi, A. (2023) · Springer eBooks · doi:10.1007/978-981-19-7952-1_5 · Cited by 5
Steiner, K., & Humpel, C. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2906232 · Cited by 4
Classification and Molecular Aspects of Neurotraumatic Diseases
Farooqui, A. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813596-9.00001-8 · Cited by 5
Adult Endogenous Dopaminergic Neuroregeneration Against Parkinson’s Disease: Ideal Animal Models?
Vijayanathan, Y., Lim, S. M., Tan, M. P., Lim, F. T., Majeed, A. B. A., & Ramasamy, K. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00298-7 · Cited by 4
Object of study — an aging brain
Ivanitskii, G. R., & Morozov, A. A. (2020) · Uspekhi Fizicheskih Nauk · doi:10.3367/ufnr.2020.06.038791 · Cited by 4
CRISPR: a tool with potential for genomic reprogramming in neurological disorders
Dhuriya, Y. K., & Naik, A. A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08136-z · Cited by 4
Comparative information of different animal models used in chronic diseases
Goel, F., Giri, A., Kumar, D., Pal, A., & Singh, P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33877-9.00014-8 · Cited by 3
Devi, A., Saini, C. S., Shiven, A., Kumar, A., Sharma, A., Joshi, N., Kour, S., Khan, Z. A., Dewangan, H. K., & Dwibedi, V. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02408-6 · Cited by 3
Advances in three-dimensional modeling of ischemic injury
Halkoluoto, A., Dhungana, H., & Keuters, M. H. (2026) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x251409022 · Cited by 3
Chen, Y., Fernandez, Z. J., Scheel, N., Gifani, M., Zhu, D. C., Counts, S., Dorrance, A. M., Razansky, D., Yu, X., Qian, W., et al. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad479 · Cited by 3
Multiorgan-on-a-chip: Design and Applications
Khan, H., Khan, S. A., & Parvez, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13782-2.00009-7 · Cited by 3
Metadata
- Authors
- Dawson, T. M., Golde, T. E., & Lagier-Tourenne, C.
- Affiliations
- Johns Hopkins University (US)
- University of Florida (US)
- Corresponding author
- Dawson, Ted M.
- Golde, Todd E.
- Venue
- Nature Neuroscience
- Published
- 2018-09-24
- Volume
- 21
- Issue
- 10
- Pages
- 1370-1379
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- PMC
- PMC6615039
- OpenAlex
- W2891411797
- Cited by
- 576
- References
- 151
- Citations by year
- 2026: 59 · 2025: 73 · 2024: 89 · 2023: 72 · 2022: 88 · 2021: 79 · 2020: 70 · 2019: 41 · 2018: 4
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01AG018454, U01AG046139, P50AG047266)
- National Cancer Institute (P01CA166009)
- National Institute of Neurological Disorders and Stroke (R21NS098006, R01NS087227, R01NS082205, P50NS038377)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- animal models, neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, frontotemporal dementia, amyotrophic lateral sclerosis, rodent models, translatability, disease modeling
- MeSH terms
- Animals, Disease Models, Animal, Humans, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review